The temperature controlled pharmaceutical containers Market is developing rapidly owing to the growing demand for temperature sensitive drugs across various application areas such as clinical trials, research laboratories, healthcare and others. These containers play a critical role in ensuring safe and effective transportation and storage of temperature sensitive drugs such as vaccines, insulin, blood products, biosimilars and monoclonal antibodies by maintaining required temperature conditions. Temperature controlled pharmaceutical containers have various advantages such as preventing temperature excursions, maintaining stability of products, minimal change in quality and safety of drugs, high reusability of dry ice containers and low cost of transportation. The increasing manufacturing and consumption of biologics, vaccines and specialty drugs which require controlled temperature for storage and distribution is driving the need for temperature controlled pharmaceutical containers Market.

The Global Temperature Controlled Pharmaceutical Containers Market is estimated to be valued at US$ 10.26 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the temperature controlled pharmaceutical containers are Cold Chain Technologies, Va-Q-Tec AG, Pelican BioThermal Limited, SOFRIGAM GROUP, Sonoco, Inmark Packaging, Snyder Industries, ACH Foam Technologies, LLC, Cryopak Industries Inc., Saeplast, Exeltainer, OMEGA Engineering, Envirotainer Ltd, Klinge Corporation, American Aerogel Corporation. Growing demand for temperature sensitive drugs across various therapeutic areas along with complex logistics of healthcare supply chain management is fueling the demand for advanced temperature controlled pharmaceutical containers. Emergence of novel active temperature control systems, phase change materials, RFID and sensor enabled containers are revolutionizing temperature controlled pharmaceutical containers market.

The Temperature Controlled Pharmaceutical Containers Market Size for temperature sensitive drugs is increasing rapidly owing to various factors such as growing prevalence of chronic diseases, new product launches, rising healthcare expenditure, complexities in drug properties and focus on value added services. Biologics based therapies for cancer, autoimmune diseases and orphan drugs drive significant growth opportunities for temperature controlled pharmaceutical containers. Technological advancements in active and passive temperature control solutions have enabled safe and effective transportation of drugs over long distances meeting all regulatory guidelines.

Market Trends

Increasing offshore clinical trial activities by pharma companies

Pharmaceutical manufacturing companies are outsourcing clinical trials to Asia Pacific and Eastern European countries owing to lower costs. This driving demand for temperature controlled solutions during international drug transportation for clinical trials.

Get more insights on Temperature Controlled Pharmaceutical Containers Market